Get 40% Off
🚨 Markets Are Down. Unlock Undervalued StocksFind Stocks Now

Healthcare Stocks: Strong, Market-Leading Start Signals a Promising 2024

Published 18/01/2024, 13:43
Updated 09/07/2023, 11:31

After a modest loss in 2023, shares in the healthcare sector (NYSE:XLV) are enjoying a market-leading rebound so far in the new year.

No one knows if it will last, but the early results certainly look encouraging after this slice of the market has pulled ahead of the rest of the field year to date, based on a set of sector ETFs through yesterday’s close (Jan. 17).

Health Care Select Sector ETF XLV has climbed 2.2% so far in January.

That’s a solid gain relative to the broad market (SPY), which has ticked down 0.6% in 2024’s opening run. Even more impressive, healthcare is outperforming all the other sectors, in some cases by wide margins.

US Equity Sectors ETF Performance

Energy stocks are currently the worst performer among US sectors. Following a modest loss in 2023 for Energy Select Sector SPDR® Fund (NYSE:XLE), the weakness has spilled over into 2024 with a year-to-date decline of 4.5%.

The technical profile for several health stocks looks attractive, advises Renaissance Macro’s Jeff DeGraaf, who points to the return of the so-called golden cross: 50-day moving average rising above its 200-day counterpart.

“Several healthcare names are exhibiting golden crosses, and we continue to believe the prospects for the sector are attractive for 2024,” he tells MarketWatch.

By that reasoning, XLV also looks attractive in the wake of its 50-day average again rising above its 200-day average.

Skeptics will note that we’ve seen this indicator issue several false signals in recent years while the fund has remained in a trading range.

3rd party Ad. Not an offer or recommendation by See disclosure here or remove ads .

XLV-Daily Chart

What’s different this time, which investors in healthcare shares hope may signal an enduring bull run: XLV has finally broken out of its trading range on the upside this month (after several failed attempts in recent years).

Does it all add up to a favorable trend signal for healthcare shares in 2024? The odds appear to be leaning a bit more in that direction so far this month.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.